CTOs on the Move

DDB Corbett

www.ddbcorbett.com

 
DDB Corbett is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hunter Pharmacy

Hunter Pharmacy is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Hunter Pharmacy is based in Austin, TX. You can find more information on Hunter Pharmacy at www.hunterpharmacy.com

Arrow International (Teleflex Incorporated)

Arrow International (Teleflex Incorporated) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Arrow International (Teleflex Incorporated) is based in Reading, PA. You can find more information on Arrow International (Teleflex Incorporated) at www.arrowintl.com

Dufort et Lavigne

Dufort et Lavigne is a Montreal-Est, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endologistic

Endologistic is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.